Methods and Technologies

The Methods and Technologies Branch in NCI’s Epidemiology and Genomics Research Program supports innovative cancer epidemiology research, including development and adaptation of laboratory and technical approaches for large studies in human populations.

Learn More About

Program Directors

Investigators seeking grant funding for methods and technologies projects are encouraged to contact scientific staff in the Methods and Technologies Branch (MTB) with questions.

MTB Program Directors

Featured Funding Opportunities

Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-313 (UH2/UH3 - Clinical Trial Not Allowed) and PAR-20-314 (UH3 - Clinical Trial Not Allowed)
Expires October 11, 2023

NCI Small Grants Program for Cancer Research
PAR-20-052 (NCI R03 Omnibus - Clinical Trial Optional)
Expires January 8, 2023

Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers
PAR-20-052
Expires January 8, 2023

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants
PAR-20-074 (R01 - Clinical Trial Not Allowed)
Expires October 29, 2022

View all FOAs related to cancer control research.

Interest Areas

Learn more about MTB’s interests in the following areas, relevant funding opportunity announcements, related EGRP events, and staff contacts.

Biomarkers

EGRP is interested in supporting research that improves understanding of how biomarkers can be used in early detection/screening of cancer.

Epigenomics and Epigenetics

EGRP is interested in supporting research to increase understanding of processes that regulate how and when certain genes are turned on and off may be deregulated in cancer.

Health Disparities

Staff in EGRP partner with others at NCI and NIH to foster research to better understand the causes of health disparities and develop interventions to reduce differences in the incidence, prevalence, mortality, and burden of cancer and related adverse health conditions that exist among specific population groups in the United States.

Infectious Agents

EGRP partners with others at NCI and NIH to foster investigator-initiated research to better understand the role of infectious agents in cancer.

Microbiome Research

Staff in EGRP partner with others at NCI and NIH to foster analysis of the microbiome and associated metabolites that may assist in the understanding of microbial exposures and their association with disease risk, incidence, progression, and treatment response.
Last Updated: 10 Dec, 2020